table of contents the pharmaceutical industry key events and trends shaping its current status future direction a review in 2005 analysis expected to impact this market 2006 beyond product code dmhc2168 price 7600 publication date 29 mar overview introduction despite tough year terms regulatory environment public opinion with withdrawal vioxx still at forefront peoples minds number leading pharmas continued drive impressive growth biologicals lead genentech s cancer focused portfolio driving fastest forecast do same scope examines performance pharma companies reveal winners losers by sales share identifies products considers patent expiries that are slow over coming explores will shape highlights was growing top 50 biotech
